Diabetes Cohort in French Amazonia (CoDiAm)

CoDiAm aims to collect clinical, biological and social data of diabetic patients in French Guiana.

Study Overview

• Status: Unknown
• Conditions: Diabetes Mellitus; Adults

Detailed Description

Diabetes is a very common disease in French Guiana. This disease is caused by the body's inability to metabolise sugar properly. A diet and treatment with tablets are enough for some patients, while others may need insulin injections. In the long term, high blood sugar levels may cause problems to the small and large blood vessels in the body. This is complicated by nerve, renal and retinal damage, as well as increased risks of cardiac and vascular events (such as strokes or heart attacks.) It appears that diabetes is more common and more severe in French Guiana than in other parts of France. It seems that the types of diabetes found here are more variable than those found in France, and that patients tend to be diagnosed at a later stage. We would this like to better understand diabetes and its evolution in French Guiana.

This research is aimed at diabetic patients and it is being carried out in the Andrée Rosemon Hospital Centre, the Ouest Guyanais Hospital Centre as well as in other Primary Healthcare Centres. At some point in the future, some private health centres may also invite their patients to take part in this study.

• Study Type: Observational
• Enrollment (Anticipated): 3000

Contacts and Locations

Study Locations

• France
  • French Guiana
    • Cayenne, French Guiana, France, 97306
      • Recruiting
      • Centre Hospitalier de Cayenne
      • Contact: Mathieu Nacher, MD, PhD; Phone Number: 5024 +594594395024; Email: mathieu.nacher@ch-cayenne.fr
      • Contact: DRCI CAYENNE; Phone Number: +5945945385; Email: cicec@ch-cayenne.fr
      • Principal Investigator: Nadia SABBAH, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Diabetic patients living in French Guiana

Description

Inclusion Criteria:

• Patients with diabetes
• At least 18 years old

Exclusion Criteria:

• Less than 18 years old
• Patients under legal guardianship
• Patients' refusal to participate
• Patients living outside French Guiana

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Improvement of patient care	Number of health complications in diabetes mellitus ...	2 years

Collaborators and Investigators

• Sponsor: Centre Hospitalier de Cayenne

Study record dates

Study Major Dates

• Study Start (Actual): April 8, 2019
• Primary Completion (Anticipated): April 8, 2021
• Study Completion (Anticipated): May 8, 2021

Study Registration Dates

• First Submitted: July 10, 2019
• First Submitted That Met QC Criteria: July 12, 2019
• First Posted (Actual): July 15, 2019

Study Record Updates

• Last Update Posted (Actual): July 15, 2019
• Last Update Submitted That Met QC Criteria: July 12, 2019
• Last Verified: July 1, 2019

More Information

Terms related to this study

• Keywords: French Guiana; Diabete
• Additional Relevant MeSH Terms: Glucose Metabolism Disorders; Metabolic Diseases; Endocrine System Diseases; Diabetes Mellitus
• Other Study ID Numbers: CODIAM

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No